Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	2.74	22.79	22.18
Graham Fair Price	-41.82	3049.09	5240.65
PEG	608.28	-0.28	0.04
Price/Book	5.62	0.55	0.52
Price/Cash Flow	-13.42	2.22	-2.56
Prices/Earnings	202.11	37.04	-12.26
Price/Sales	-5.43	0.47	0.50
Price/FCF	-13.42	2.22	-2.56
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-2.48	0.11	0.11
Operating Margin	-13.56	0.03	0.03
ROA	-67.56	< 0.005	< 0.005
ROE	-0.01	< 0.005	-65.04
ROIC	< 0.005	< 0.005	-44.18
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.03	0.05	-41.44
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	0.18	-0.04	-79.59
EPS QOQ	-3.15	1.34	-57.35
FCF QOQ	-1.74	2.22	27.24
Revenue QOQ	-0.03	0.11	336.59
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	26.76	19.39	-27.53
Days Sales Outstanding (DSO)	32.56	33.22	2.02
Inventory Turnover	3.36	4.64	37.98
Debt/Capitalization	0.69	0.70	1.09
Quick Ratio	0.38	0.52	34.81
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	10689.57	10518.65	-1.60
Cash	3460.15	6550.93	89.32
Capex	-239.83	-370.19	-54.36
Free Cash Flow	-2187.17	2625.55	20.04
Revenue	11167.58	12272.80	9.90
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.61	0.69	14.24
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	18.02	18.05	0.21
Naive Interpretation	Member

06 - Financial Health · Bad

Rating